Subtype
Non-Functioning Pancreatic Neuroendocrine Tumor
CI-CAN-00001286Explore in graph →
Non-malignant1 active trials
- NCIt
- C45837
Loading cancer entity…
Subtype
CI-CAN-00001286Explore in graph →
Clinical trials
8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02831179 | Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor | withdrawn | Phase 1 | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Sep 28, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Sep 28, 2017source: clinicaltrials